Denmark

Loading...

DKK overview

PairLatest rateToday's change1 year change
DKKGBP0.1132
GBP
-0.0002 / -0.13%-0.0032 / -2.73%
Today
0.113Oct 07 20260.1187Nov 14 2025
DKKEUR0.1338
EUR
-0.00002 / -0.02%-0.0002 / -0.12%
Today
0.1333Mar 23 20260.1347Mar 09 2026
DKKUSD0.1498
USD
-0.0002 / -0.13%-0.0051 / -3.29%
Today
0.1493Oct 05 20260.1618Jan 27 2026
DKKJPY23.72
JPY
0.0426 / 0.18%0.0161 / 0.07%
Today
23.40Oct 17 202525.15Apr 17 2026
DKKAUD0.2144
AUD
-0.0011 / -0.53%-0.0218 / -9.22%
Today
0.2143Oct 09 20260.2432Oct 17 2025
DKKCAD0.2136
CAD
0.0003 / 0.12%-0.0036 / -1.63%
Today
0.2089Mar 09 20260.2205Oct 17 2025
DKKCNY1.00
CNY
-0.0022 / -0.22%-0.101 / -9.15%
1.00Oct 09 20261.00Oct 09 2026
DKKCHF0.1244
CHF
-0.0004 / -0.28%-0.0005 / -0.39%
Today
0.1202Mar 09 20260.1269Sep 30 2026

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Denmark in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the OMX Copenhagen 20 with the highest percent gain over one day.
ListingLastChangeVolume
Demant A/SDEMANT:CPH341.20
DKK
+19.80
+6.16%
679.64k
Genmab A/SGMAB:CPH2,445.00
DKK
+89.00
+3.78%
99.24k
Tryg A/STRYG:CPH148.50
DKK
+4.60
+3.20%
1.18m
Coloplast A/SCOLO B:CPH435.90
DKK
+11.40
+2.69%
311.87k
Rockwool A/SROCK B:CPH183.80
DKK
+4.80
+2.68%
381.23k
Oersted A/SORSTED:CPH132.45
DKK
+2.90
+2.24%
1.03m
Novo Nordisk A/SNOVO B:CPH255.25
DKK
+5.35
+2.14%
5.04m
Pandora A/SPNDORA:CPH821.00
DKK
+15.40
+1.91%
150.69k
Novozymes A/SNSIS B:CPH435.10
DKK
+7.20
+1.68%
677.11k
Vestas Wind Systems A/SVWS:CPH189.70
DKK
+2.80
+1.50%
1.37m
Data delayed at least 15 minutes, as of Oct 09 2026 15:59 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.